Skip to main content
. 2021 Feb 4;20:199–222. doi: 10.17179/excli2021-3413

Table 3. Adjusted mortality risk in laboratory-confirmed COVID-19 patients receiving antivirals, oseltamivir, or antibiotics after propensity score matching.

Table 3